HIFU Treatment · November 14, 2026
Does Fibroid HIFU Hurt? Pain Control and Monitoring on Treatment Day
Ultrasound-guided HIFU for uterine fibroids can cause pain or discomfort, even though it does not involve a surgical incision. Pain relief and sedation may form part of the treatment plan, but a promise of completely painless treatment is not a sound basis for choosing it. Before consenting, ask how comfort will be managed, who will monitor you, and how you can alert the team if something changes. [1-3]
Incision-free does not mean sensation-free
HIFU focuses ultrasound energy on a target inside the uterus to heat and ablate tissue. In ultrasound-guided treatment, diagnostic ultrasound helps the operator identify and observe the target during treatment. NICE describes treatment in a face-down position, with intravenous sedation as a possible way to minimise movement. [1]
Pain is one of the safety outcomes NICE considers important, alongside skin burns and injury to nearby structures. Discomfort should therefore be part of an honest consent discussion, rather than dismissed because the treatment is described as non-invasive. [2]
There is no single pain score that can predict your experience. Published protocols, medicines and patient groups differ. A small single-centre study of ultrasound-guided HIFU describes both intraprocedural pain-management challenges and occasional substantial pain afterwards; it cannot establish what an individual at another clinic will feel. [3]
Pain relief and sedation are related, but not identical
Analgesia means pain relief. Sedation aims to reduce alertness or anxiety to a degree selected by the clinical team. Feeling sleepy and having adequate pain relief are not interchangeable goals. Ask what each part of the proposed plan is intended to do.
NICE says intravenous sedation may be used for ultrasound-guided HIFU. That wording does not establish a universal requirement for general anaesthesia, a particular drug, or a particular sedation depth. The published single-centre study also describes more than one medication regimen, not a standard that every centre must copy. [1,3]
A useful discussion covers:
- Whether sedation is planned, and what level of awareness is intended.
- How pain will be assessed and treated during the procedure.
- Who is responsible for giving medicines and monitoring their effects.
- How the team will respond if pain is not controlled or sedation affects breathing.
- What options exist if you cannot comfortably maintain the required position.
Do not take extra sleeping tablets, sedatives or pain medicines to prepare yourself unless the treating team has specifically instructed you to do so. Give the team an accurate list of prescribed medicines, non-prescription products and allergies, and obtain individual instructions rather than changing medication on your own.
Agree on a way to report discomfort before treatment starts
In one published ultrasound-guided HIFU protocol, sedation was intended to let patients tolerate treatment while remaining able to report major pain or symptoms suggestive of nerve irritation. This is an example from a particular centre, not confirmation of BARUN's sedation protocol. [3]
Ask how communication will work in your own plan. Will you be able to speak? Is there another agreed signal? If you need interpretation, how will a new symptom be communicated promptly? Resolve this before treatment, not only when you are uncomfortable.
Tell the team promptly about new, increasing or unusual pain. Describe where it is, what it feels like, and when it started. In particular, report a burning skin sensation, pain spreading into the buttock or leg, or a new tingling sensation rather than assuming it is something you must endure. Skin burns and nerve-related symptoms are recognised concerns in the ultrasound-guided HIFU literature. [2,3]
You are not expected to diagnose the cause or decide how the equipment should be adjusted. Your role is to report the change; the clinical team must assess it and decide whether treatment needs to pause, change or stop. A wish to complete treatment should not make you feel obliged to stay silent.
Monitoring involves more than watching the fibroid image
Real-time ultrasound guidance helps the operator observe the target. It does not replace assessment of your comfort or the effects of sedation. The published ultrasound-guided HIFU study describes physiological monitoring and highlights pain control, breathing-related sedation risks and body-temperature management as important concerns. [1,3]
Before your appointment, ask who will monitor your breathing and other vital signs, who you should alert, and what response is available if you become unwell. Also ask how the team checks the skin and responds to unexpected pain or temperature changes. These are questions about the proposed care plan, not a checklist that proves a procedure is safe in every circumstance.
Neither being able to report pain nor using imaging guarantees that a burn or another injury cannot occur. NICE identifies well-recognised complications, including skin burns, and considers the quality of efficacy evidence limited. Its UK recommendation is to use this procedure with special arrangements for clinical governance, consent, and audit or research. That recommendation is not an endorsement or accreditation of a particular Korean clinic. [2]
Information to share before the treatment day
Tell the treating team about previous problems with anaesthesia or sedation, allergies, breathing conditions, regular medicines and any current illness. Mention pain, restricted movement or anxiety that could make lying face down difficult. If pregnancy is possible or your symptoms have changed since assessment, tell the team before proceeding.
Request written, individual instructions about eating and drinking, usual medicines, arrival arrangements, and any escort or transport requirements. An online article cannot set those instructions for you. The necessary preparation and discharge arrangements depend on the actual treatment and sedation plan.
At BARUN, the confirmed treatment modality is ultrasound-guided HIFU. This article does not confirm a particular anaesthetic drug, sedation depth, staffing arrangement, treatment duration or length of stay. Obtain those details from the treating team for your own proposed procedure. MRI-guided focused ultrasound is a separate technique; its protocols should not automatically be applied to ultrasound-guided treatment.
If the proposed plan does not fit your needs
Pain control is one part of deciding whether HIFU is appropriate, not the only consideration. Diagnosis, imaging, symptoms, reproductive plans, risks and alternatives still matter. Depending on the individual situation, discussion may include medicines, uterine artery embolisation or surgery. NICE lists several medical, radiological and surgical approaches for symptomatic fibroids. [1]
If you cannot tolerate the position, have concerns about sedation or do not understand the safety plan, raise those concerns before consenting. The answer may be a clarified or revised plan, further assessment, or another treatment. HIFU is not something you must accept simply because you want to avoid an incision.
Frequently asked questions
Will I definitely be asleep?
No universal answer applies. NICE describes intravenous sedation as an option for ultrasound-guided HIFU, not a guarantee of being asleep. Ask about the intended level of awareness and how communication will be maintained in your specific plan. [1,3]
Does pain mean that the treatment is working?
Pain is not a target or proof of successful ablation. Report it so the team can assess your comfort and safety. Do not try to tolerate more pain in the belief that this will improve the result.
Can I ask for treatment to pause?
Agree beforehand on how to request help or a pause. Tell the team if pain becomes difficult to tolerate or you feel unwell. The clinician should assess what is happening and explain whether it is appropriate to resume, modify or stop treatment.
Can a study tell me which sedation drug is best for me?
Not by itself. The study discussed here is an observational report from one centre, not proof that one regimen is best for all patients. Choice of medicines and monitoring requires individual clinical assessment. No drug doses or self-medication instructions are provided here. [3]
Related reading
Sources and evidence limits
- NICE HTG523: The condition, current treatments and procedure. Published 24 July 2019; checked 12 November 2026. Describes ultrasound-guided HIFU, including optional intravenous sedation and continuous ultrasound imaging. It does not specify a universal analgesic regimen.
- NICE HTG523: Recommendations and Committee considerations. Checked 12 November 2026. Covers evidence limitations, special governance arrangements, consent and key safety outcomes. The guidance's move from IPG657 to HTG523 did not change its recommendations.
- Multidisciplinary management to optimize outcome of ultrasound-guided high-intensity focused ultrasound (HIFU) in patients with uterine fibroids. Scientific Reports, 2021; checked 12 November 2026. Observational single-centre report involving 40 patients. Its monitoring and sedation practices illustrate one centre's approach; they do not establish a universal protocol, an individual complication probability or BARUN-specific outcomes.
Prepared with AI assistance by Aside AI, 12 November 2026. General health education only, not a diagnosis or an individual treatment recommendation.